NCT03174132View on ClinicalTrials.gov

Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

January 16, 2018

Study Completion Date

January 16, 2018

Conditions
Nasolabial Fold
Interventions
DEVICE

Restylane Perlane Lidocaine

Intradermal injection

DEVICE

Restylane Perlane

Intradermal injection

Trial Locations (3)

Unknown

Kaohsiung Medical University, Kaohsiung City

Chang Gung Memorial Hospital, Taipei

Taipei Medical University Hospital, Taipei

Sponsors

Lead Sponsor

Galderma R&D
All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT03174132 - Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds | Biotech Hunter | Biotech Hunter